Focal hyperhidrosis is a quantitative disturbance of sweat function which may involve multiple areas. It is a chronic condition and can cause the patient severe problems in social and professional relationships. Conventional treatments have proved to be marginally effective, impractical and/or with potentially significant side effects. Botulinum toxin type A is capable of blocking the cholinergic transmission to the eccrine glands, thus inhibiting sweat production. A series of 53 patients treated with Botulinum toxin for focal hyperhidrosis of multiple areas is reported. Intradermal injections of 2 mU were performed every 1.5 cm2, with an average dose of 40 mU for each axilla, 50–60 mU for each palm and sole. The treatment has proved to be very effective in most cases, with the best results in the axilla. The mean duration of the effect was 6 months.
European Journal of Plastic Surgery – Springer Journals
Published: Jul 17, 2000
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera